Could a safer, No-Needle MRI replace Dye-Based breast scans?

NCT ID NCT05006196

Ongoing Diagnosis Sponsor: Perspectum Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study is testing whether a special MRI that does not require a contrast dye injection can accurately detect breast cancer or other breast diseases. Over 1,000 women at risk or with suspected breast issues will receive the new MRI alongside standard care. The goal is to see if this safer, more comfortable approach can match or beat current methods.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a safer, needle-free MRI method for breast cancer screening, reducing patient discomfort and risk from contrast agents.
What could go wrong: This is an early observational study, not a treatment trial. The new MRI technique may not be as accurate as standard methods, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast disorder breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER BREAST DISEASES

Contacts and locations

Locations

Gemini One

Oxford, OX4 2LL, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.